NJ State Employees Deferred Compensation Plan Holds Stake in Mylan N.V. (NASDAQ:MYL)

NJ State Employees Deferred Compensation Plan continued to hold its position in shares of Mylan N.V. (NASDAQ:MYL) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,750 shares of the company’s stock at the end of the second quarter. NJ State Employees Deferred Compensation Plan’s holdings in Mylan N.V. were worth $573,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First Personal Financial Services boosted its position in shares of Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock valued at $107,000 after buying an additional 681 shares during the last quarter. Global X Management Co. LLC boosted its position in shares of Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after buying an additional 1,441 shares during the last quarter. Ropes Wealth Advisors LLC acquired a new position in shares of Mylan N.V. during the first quarter valued at approximately $136,000. Oakworth Capital Inc. boosted its position in shares of Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock valued at $166,000 after buying an additional 1,000 shares during the last quarter. Finally, State of Alaska Department of Revenue acquired a new position in shares of Mylan N.V. during the first quarter valued at approximately $188,000. Hedge funds and other institutional investors own 70.19% of the company’s stock.

Shares of Mylan N.V. (NASDAQ MYL) opened at 32.00 on Tuesday. The firm has a market capitalization of $17.15 billion, a P/E ratio of 31.97 and a beta of 1.27. The stock has a 50 day moving average of $38.42 and a 200-day moving average of $39.28. Mylan N.V. has a 1-year low of $31.47 and a 1-year high of $50.40.

Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings data on Wednesday, May 10th. The company reported $0.93 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.92 by $0.01. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The company had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.81 billion. During the same quarter in the previous year, the firm earned $0.76 earnings per share. Mylan N.V.’s revenue was up 24.1% on a year-over-year basis. On average, equities analysts expect that Mylan N.V. will post $5.16 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.themarketsdaily.com/2017/08/08/nj-state-employees-deferred-compensation-plan-holds-stake-in-mylan-n-v-nasdaqmyl.html.

Several research analysts recently commented on the stock. Royal Bank Of Canada set a $41.00 target price on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Saturday, May 13th. Morgan Stanley dropped their price target on shares of Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a research report on Monday. Cowen and Company reaffirmed a “market perform” rating and set a $43.00 price target (down from $55.00) on shares of Mylan N.V. in a research report on Sunday, May 21st. Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Finally, BidaskClub raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, June 22nd. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $50.21.

In other Mylan N.V. news, insider Anthony Mauro sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the sale, the insider now owns 140,653 shares of the company’s stock, valued at $5,626,120. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now directly owns 799,855 shares of the company’s stock, valued at approximately $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply